Tagged with amr

France Stewart Cole, president of Institut Pasteur, speaks out about his aspirations as the first foreign president of the institute and the main themes of the new strategic plan.   Brexit is a great tragedy for everyone and it is a concerning development for Britain and Europe in my opinion. It…

Regulation As deputy director of health and nutrition at the European Commission EC, Martin Seychell has a lot on his plate if we are to achieve the UN Sustainable Development Goals (SDGs) –which aim to significantly improve life for all people on earth by 2030. One of the biggest challenges we face in…

Europe At last week’s European Health Forum Gastein (EHFG), the theme surrounded the United Nations Sustainable Development Goals (SDGs) for 2030. Out of the 17 SDGs, 12 are in some way connected to health and nutrition. In attendance were key stakeholders in European health including Martin Seychell, deputy director of health…

UK One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in 2017, UK charities poured GBP 1.6 billion (USD 2.1 billion) into medical research; more than both the Medical Research Council (MRC) and the National Institute for Health Research (NIHR). Simon Gillespie, chief…

UK Aisling Burnand, CEO of the Association of Medical Research Charities (AMRC), shares the organization’s vision and the significant contributions of its member charities to the life sciences R&D ecosystem in the UK. She also outlines some of the main trends within the sector including digitalization and new models of fundraising,…

Pharma Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5 times and the company is building a position as a regional leader in the Middle Eastern nutraceuticals market. In 2011,…

Pharma Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position taken up by Janssen in the oncology field, and calls on Dutch healthcare stakeholders to adopt the positive and collaborative attitude that will ensure Dutch patients can still expect to access the most innovative…